Inevitable re rate pending20 Jan 2026 08:29
Oxford BioDynamics Plc is in Nature—
Honoured to see our work featured in Nature Magazine, covering progress toward the first, long-overdue, accurate blood test for #ChronicFatigueSyndrome (#MECFS)—a breakthrough step for #OBD that, once clinically validated, could greatly shorten the path to diagnosis and help uncover therapeutic pathways. We’re committed to translating rigorous science into real-world impact for people living with ME/CFS.
An accurate blood test for CFS will change the landscape of modern medicine. With its high accuracy and pending validation it’s the star gem in the portfolio. Worth holding out for this alone when the clinical validation news lands and it becomes commercially ready.